Johnson Matthey completion of Health sale

RNS Number : 4645N

Johnson Matthey PLC

01 June 2022

 

Johnson Matthey announces completion of Health sale

1 June 2022

Johnson Matthey Plc (JM), a global leader in sustainable technologies, today announces that that it has completed the sale of its Health business in accordance with the terms of the sale agreement entered into between JM and Altaris Capital Partners ("Altaris"), a leading healthcare investment firm.

The Health business, which has been rebranded as Veranova, was sold for a total consideration of £325 million. As part of the transaction, JM will retain approximately a 30% equity stake in Veranova.

ENDS

Johnson Matthey is a global leader in sustainable technologies that enable a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today about 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

Inspiring science, enhancing life

For further information

Media

[e-mail]

0207 269 8001

Investor Relations

Martin Dunwoodie  Director of Investor Relations  0207 269 8241

Louise Curran           Senior Investor Relations Manager           0207 269 8235

Carla Fabiano           Senior Investor Relations Manager           0207 269 8004

 

END

 

 

DISABMFTMTTJBIT